David M Denton
CIK 1428718 · View on SEC EDGAR ↗
First SEC filing: April 5, 2022 · Latest: April 5, 2022
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 29, 2018 | CVS | S | 25,159 | $80.13 | $2,015,991 | 403 Direct | -98.42% | Disposed | 19.3% (price as of 2026-08-19) |
| Sept. 11, 2017 | CVS | S 10b5-1 | 108,183 | $79.62 | $8,613,530 | 36,056 Direct | -75.00% | Disposed | 20.1% (price as of 2026-08-19) |
| Sept. 11, 2017 | CVS | S 10b5-1 | 105,040 | $79.68 | $8,369,587 | 36,056 Direct | -74.45% | Disposed | 20.0% (price as of 2026-08-19) |
| Sept. 11, 2017 | CVS | S 10b5-1 | 23,855 | $79.61 | $1,899,097 | 141,096 Direct | -14.46% | Disposed | 20.1% (price as of 2026-08-19) |
| June 12, 2017 | CVS | S 10b5-1 | 230,510 | $80.00 | $18,440,800 | 164,563 Direct | -58.35% | Disposed | 19.5% (price as of 2026-08-19) |
| March 10, 2017 | CVS | S 10b5-1 | 95,618 | $80.68 | $7,714,460 | 154,717 Direct | -38.20% | Disposed | 18.5% (price as of 2026-08-19) |
Showing latest 100 of 160 transactions
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 3, 2026 | HONA | Restricted Stock Units | Common Stock (572) | — | — | 572 | Acquired |
| June 29, 2026 | HONA | Deferred Compensation (Phantom Shares) | Common Stock (135) | — | — | 135 | Acquired |
| March 3, 2026 | PFE | Stock Appreciation Rights | Common Stock (216,537) | $26.58 | March 3, 2031 | 216,537 | Acquired |
| March 4, 2025 | PFE | Stock Appreciation Rights | Common Stock (413,138) | $25.75 | March 4, 2030 | 413,138 | Acquired |
| Sept. 12, 2024 | PFE | Stock Appreciation Rights | Common Stock (103,320) | $42.30 | Feb. 23, 2028 | 103,320 | Disposed |
| Sept. 12, 2024 | PFE | Stock Appreciation Rights | Common Stock (103,320) | $42.30 | Feb. 23, 2030 | 103,320 | Acquired |
| Sept. 12, 2024 | PFE | Stock Appreciation Rights | Common Stock (80,703) | $53.04 | May 31, 2027 | 80,703 | Disposed |
| Sept. 12, 2024 | PFE | Stock Appreciation Rights | Common Stock (80,703) | $53.04 | May 31, 2029 | 80,703 | Acquired |
| Feb. 27, 2024 | PFE | Stock Appreciation Rights | Common Stock (161,160) | $26.89 | Feb. 27, 2029 | 161,160 | Acquired |
| Feb. 27, 2024 | PFE | Stock Appreciation Rights | Common Stock (142,400) | $26.89 | Feb. 27, 2031 | 142,400 | Acquired |
| Feb. 23, 2023 | PFE | Stock Appreciation Rights | Common Stock (103,320) | $42.30 | Feb. 23, 2028 | 103,320 | Acquired |
| Feb. 23, 2023 | PFE | Stock Appreciation Rights | Common Stock (89,920) | $42.30 | Feb. 23, 2030 | 89,920 | Acquired |
| Nov. 15, 2022 | TPR | Stock Option [F2] | Common Stock (6,822) | $34.98 | Nov. 15, 2032 | 6,822 | Acquired |
| May 31, 2022 | PFE | Stock Appreciation Rights | Common Stock (80,703) | $53.04 | May 31, 2027 | 80,703 | Acquired |
| May 31, 2022 | PFE | Stock Appreciation Rights | Common Stock (70,313) | $53.04 | May 31, 2029 | 70,313 | Acquired |
| April 1, 2022 | LOW | Non-Qualified Stock Option (right to buy) | Common Stock (18,265) | $202.40 | April 1, 2032 | 18,265 | Acquired |
| April 1, 2022 | LOW | Performance Share Units | Common Stock (38,220) | — | — | 38,220 | Disposed |
| March 17, 2022 | LOW | Performance Share Units | Common Stock (38,220) | — | — | 38,220 | Acquired |
| Nov. 3, 2021 | TPR | Stock Option [F2] | Common Stock (5,523) | $41.82 | Nov. 3, 2031 | 5,523 | Acquired |
| April 1, 2021 | LOW | Non-Qualified Stock Option (right to buy) | Common Stock (21,593) | $191.32 | April 1, 2031 | 21,593 | Acquired |
| Nov. 5, 2020 | TPR | Stock Option [F2] | Common Stock (7,282) | $24.71 | Nov. 5, 2030 | 7,282 | Acquired |
| April 1, 2020 | LOW | Non-Qualified Stock Option (right to buy) | Common Stock (57,141) | $80.42 | April 1, 2030 | 57,141 | Acquired |
| Nov. 7, 2019 | TPR | Stock Option [F2] | Common Stock (13,069) | $27.07 | Nov. 7, 2029 | 13,069 | Acquired |
| April 1, 2019 | LOW | Non-Qualified Stock Option (right to buy) | Common Stock (41,900) | $108.93 | April 1, 2029 | 41,900 | Acquired |
| Jan. 2, 2019 | LOW | Non-Qualified Stock Option (right to buy) | Common Stock (40,700) | $92.27 | Jan. 2, 2029 | 40,700 | Acquired |
| Nov. 8, 2018 | TPR | Stock Option [F2] | Common Stock (7,712) | $43.03 | Nov. 8, 2028 | 7,712 | Acquired |
| April 1, 2018 | CVS | Stock Option | Common Stock (116,767) | $62.21 | April 1, 2025 | 116,767 | Acquired |
| Feb. 20, 2018 | CVS | Stock Option | Common Stock (10,869) | $78.05 | April 3, 2024 | 10,869 | Disposed |
| Feb. 20, 2018 | CVS | Stock Option | Common Stock (22,716) | $104.82 | April 1, 2023 | 22,716 | Disposed |
| Feb. 20, 2018 | CVS | Stock Option | Common Stock (25,540) | $102.26 | April 1, 2022 | 25,540 | Disposed |
| Feb. 20, 2018 | CVS | Stock Option | Common Stock (30,325) | $74.29 | April 1, 2021 | 30,325 | Disposed |
| Nov. 9, 2017 | TPR | Stock Option [F2] | Common Stock (9,338) | $40.16 | Nov. 9, 2027 | 9,338 | Acquired |
| Sept. 11, 2017 | CVS | Stock Option | Common Stock (108,183) | $54.53 | April 1, 2020 | 108,183 | Disposed |
| June 12, 2017 | CVS | Stock Option | Common Stock (107,178) | $34.96 | April 1, 2018 | 107,178 | Disposed |
| June 12, 2017 | CVS | Stock Option | Common Stock (110,912) | $45.07 | April 2, 2019 | 110,912 | Disposed |
| June 12, 2017 | CVS | Stock Option | Common Stock (12,420) | $40.28 | March 5, 2018 | 12,420 | Disposed |
| April 3, 2017 | CVS | Stock Option | Common Stock (100,179) | $78.05 | April 3, 2024 | 100,179 | Acquired |
| March 10, 2017 | CVS | Stock Option | Common Stock (95,618) | $36.23 | April 1, 2017 | 95,618 | Disposed |
| Nov. 10, 2016 | TPR | Stock Option [F2] | Common Stock (11,284) | — | Nov. 10, 2026 | 11,284 | Acquired |
| April 1, 2016 | CVS | Stock Option | Common Stock (71,696) | $104.82 | April 1, 2023 | 71,696 | Acquired |
| Nov. 4, 2015 | TPR | Stock Option [F2] | Common Stock (11,734) | — | Nov. 4, 2025 | 11,734 | Acquired |
| Nov. 4, 2015 | TPR | Restricted Stock Unit | Common Stock (2,330) | — | — | 2,330 | Disposed |
| Nov. 4, 2015 | TPR | Restricted Stock Unit [F2] | Common Stock (2,323) | — | — | 2,323 | Acquired |
| Sept. 28, 2015 | TPR | Restricted Stock Unit [F1] | Common Stock (28) | — | — | 28 | Acquired |
| June 29, 2015 | TPR | Restricted Stock Unit [F1] | Common Stock (22) | — | — | 22 | Acquired |
| May 9, 2015 | TPR | Restricted Stock Unit | Common Stock (1,847) | — | — | 1,847 | Disposed |
| April 1, 2015 | CVS | Stock Option | Common Stock (59,922) | $102.26 | April 1, 2022 | 59,922 | Acquired |
| March 30, 2015 | TPR | Restricted Stock Unit [F1] | Common Stock (33) | — | — | 33 | Acquired |
| Dec. 29, 2014 | TPR | Restricted Stock Unit [F1] | Common Stock (36) | — | — | 36 | Acquired |
| Nov. 6, 2014 | TPR | Stock Option [F1] | Common Stock (11,321) | — | Nov. 6, 2024 | 11,321 | Acquired |
| Nov. 6, 2014 | TPR | Restricted Stock Unit [F1] | Common Stock (2,241) | — | — | 2,241 | Acquired |
| Sept. 29, 2014 | TPR | Restricted Stock Unit [F1] | Common Stock (16) | — | — | 16 | Acquired |
| July 1, 2014 | CVS | Stock Option | Common Stock (48,178) | $28.10 | April 1, 2016 | 48,178 | Disposed |
| July 1, 2014 | CVS | Stock Option | Common Stock (26,811) | $41.17 | April 1, 2015 | 26,811 | Disposed |
| June 30, 2014 | TPR | Restricted Stock Unit [F1] | Common Stock (18) | — | — | 18 | Acquired |
| May 9, 2014 | TPR | Stock Option [F1] | Common Stock (9,226) | — | May 9, 2024 | 9,226 | Acquired |
| May 9, 2014 | TPR | Restricted Stock Unit [F1] | Common Stock (1,781) | — | — | 1,781 | Acquired |
| April 1, 2014 | CVS | Stock Option | Common Stock (62,943) | $74.29 | April 1, 2021 | 62,943 | Acquired |
| Jan. 3, 2014 | CVS | Stock Option | Common Stock (14,113) | $34.42 | April 2, 2014 | 14,113 | Disposed |
| April 1, 2013 | CVS | Stock Option | Common Stock (108,183) | $54.53 | April 1, 2020 | 108,183 | Acquired |
| Sept. 13, 2012 | CVS | Stock Option | Common Stock (11,526) | $30.04 | April 3, 2013 | 11,526 | Disposed |
| Sept. 13, 2012 | CVS | Stock Option | Common Stock (11,526) | $30.04 | April 3, 2013 | 11,526 | Acquired |
| April 2, 2012 | CVS | Stock Option | Common Stock (110,912) | $45.07 | April 2, 2019 | 110,912 | Acquired |
| Sept. 14, 2011 | CVS | Stock Option | Common Stock (5,334) | $22.44 | Jan. 5, 2012 | 5,334 | Disposed |
| April 1, 2011 | CVS | Stock Option | Common Stock (107,178) | $34.96 | April 1, 2018 | 107,178 | Acquired |
| March 4, 2011 | CVS | Stock Option | Common Stock (5,000) | $30.26 | March 7, 2011 | 5,000 | Disposed |
| April 1, 2010 | CVS | Stock Option | Common Stock (95,618) | $36.23 | April 1, 2017 | 95,618 | Acquired |
| April 1, 2009 | CVS | Stock Option | Common Stock (48,178) | $28.10 | April 1, 2016 | 48,178 | Acquired |
| April 1, 2008 | CVS | Stock Option | Common Stock (26,811) | $41.17 | April 1, 2015 | 26,811 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 11 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| May 9, 2022 | PFE | Common Stock | 890 | Direct |
| March 7, 2008 | CVS | Common Stock | 11,127 | Direct |
| March 7, 2008 | CVS | Common Stock (Restricted) | — | Direct |
| March 7, 2008 | CVS | Common Stock (Restricted) | — | Direct |
| March 7, 2008 | CVS | Common Stock (Restricted) | — | Direct |
| March 7, 2008 | CVS | Common Stock (Restricted) | — | Direct |
| March 7, 2008 | CVS | Common Stock | 297 | Indirect |
| March 7, 2008 | CVS | Stock Option→ Common Stock (5,334) | 5,334 | Direct |
| March 7, 2008 | CVS | Stock Option→ Common Stock (11,526) | 11,526 | Direct |
| March 7, 2008 | CVS | Stock Option→ Common Stock (5,000) | 5,000 | Direct |
| March 7, 2008 | CVS | Stock Option→ Common Stock (14,113) | 14,113 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
LOW
CFO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $959,856 | — | — | — | $2,276,778 | — | $12,556 | $7,779,201 |
| 2020 | $941,010 | — | — | — | $2,352,524 | — | $12,000 | $10,812,068 |
| 2019 | $925,000 | — | — | — | $501,840 | — | $39,092 | $5,777,182 |
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2014 | $825,000 | — | — | — | $3,975,043 | — | — | $14,684,580 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.